Thiamidol
Thiamidol is a synthetic tyrosinase inhibitor developed specifically to be more potent and more selective than older options like kojic acid or alpha-arbutin, with published clinical evidence for reducing stubborn pigmentation and age spots at a comparatively low irritation profile.
How it works
A synthetic hydroxylated tyrosine derivative that acts as a highly potent, specific inhibitor of human tyrosinase, clinically proven to reduce stubborn hyperpigmentation and age spots with a low irritation profile.
In practice, it's a reasonable step up for pigmentation that hasn't responded to gentler tyrosinase inhibitors like alpha-arbutin, before escalating to a prescription option.
How to introduce it
Wait about 5 minutes before the next step. Judging Thiamidol before week 12 means judging it before it's had time to actually work — most of what reads as "this isn't doing anything" in the first couple of weeks is just too early to tell.
- Sunscreen is mandatory daily — pigmentation actives are undone by unprotected sun exposure.
- Kojic Acid specifically: do not combine with Vitamin C (Ascorbic Acid) in the same session.
Who should be careful
Thiamidol is rated moderate risk. Patch test on your inner forearm 48 hours before first facial use, especially if your skin reacts easily to new products.
Questions people ask
A newer, more potent pigmentation-fading ingredient than kojic acid or alpha-arbutin, with real clinical backing and low irritation.
Most people see a fair result around 12 weeks of consistent use — judging earlier usually means judging too soon.
Either — Thiamidol works in both a morning and an evening routine.
Research
Selected studies and reviews on Thiamidol. Each link opens the abstract on PubMed. This is background reading, not a substitute for advice from a dermatologist.
- Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.Lima PB et al. J Eur Acad Dermatol Venereol, 2021 · PMID 33988887
- Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.Mann T et al. J Invest Dermatol, 2018 · PMID 29427586Note: Laboratory study.